# Stellate Ganglion Block (SGB) For Women for Breast Cancer

> **NCT02513329** · PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 37 (actual)

## Conditions studied

- Hot Flushes
- Hot Flashes

## Interventions

- **DRUG:** Bupivicaine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02513329
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2023-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02513329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02513329, "Stellate Ganglion Block (SGB) For Women for Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02513329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*